PMC YM-Pharma is a professionally managed GMP manufacturer of Active Pharmaceuticals and Intermediate chemicals located at Hyderabad, A.P. India. PMC Group International acquired PMC YM-Pharma in November of 2017.
The cGMP manufacturing facility of YMDCL is one of the largest fluoroquinolone drug manufacturers in India and prides itself on its zero-discharge effluent management system. It also serves the needs of Oncology, Neuropsychiatry, Gastro-Intestinal, Pulmonary Hypertension, Anti-Depressant and Anti-Migraine pharmaceuticals. PMC YM-Pharma Private Ltd plans to become a major market player in providing cost-effective generic drugs and drug intermediates to the global market. PMC YM-Pharma is part of PMC Group’s global pharmaceutical division, which also includes PMC Isochem SAS, and works closely with the latter to meet customer demand worldwide across the pharmaceutical spectrum.
Our key strengths are our strong technological base, qualified and trained people and well-equipped Quality Control and R&D laboratories. The R&D division actively engages in process development for pharmaceutical manufacturing. Our expertise is also evident in our handling of high volume Sodium Hydride reactions.
For more information, please visit the PMC YM-Pharma site by clicking here or contact us directly at email@example.com.